During the past decade, Neuro Centrum Science GmbH conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neuro Centrum Science GmbH" #1 sponsor was "Biogen" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Immunic AG" with 1 trials sponsored, "MedDay Pharmaceuticals SA" with 1 trials sponsored and "Merck KGaA, Darmstadt, Germany" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Neuro Centrum Science GmbH" are "Multiple Sclerosis" (3 trials), "Alzheimer Disease" (1 trials) and "Relapsing-Remitting Multiple Sclerosis (RRMS)" (1 trials). Many other conditions were trialed in "Neuro Centrum Science GmbH" in a lesser frequency.

Most popular intervention types in "Neuro Centrum Science GmbH" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "BI 409306" (1 trials), "Donepezil" (1 trials), "IMU-838" (1 trials), "MD1003 100mg capsule" (1 trials) and "Mavenclad®" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neuro Centrum Science GmbH" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Neuro Centrum Science GmbH". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neuro Centrum Science GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Neuro Centrum Science GmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".